Battle corona web

Newly discovered properties of Omicron contribute to its control

Omicron has undergone an evolutionary leap compared to previous variants of the virus: it replicates more in the nose and less in the bronchial tubes. This is shown by a study conducted by the Institute of Virology and Immunology (IVI) and the University of Bern, in collaboration with the Friedrich-Loeffler-Institut (FLI) in Germany. 


African swine fever:  host factors affect progression of the disease

These very important results have just been published and will contribute eventually to vaccine development.


Java script is required to display press releases. If you are unable or unwilling to activate Java script you may use the link below to access the Federal Administration News Portal, where you can read the announcements.

To the Federal Administration News Portal

Contact IVI

Institute of Virology and Immunology IVI
Sensemattstrasse 293
3147 Mittelhäusern, Switzerland

Business hours

Phone +41 (0)58 469 92 11
Fax +41 (0)58 469 92 22

In focus

Infographie  vaccin vecteur VF final mit copyright

Improved COVID-19 vector vaccine candidate

In a recent publication, scientists at the Institute of Virology and Immunology (IVI) and the University of Bern report on a Vesicular Stomatitis Virus (VSV)-vectored COVID-19 vaccine candidate.

Rennende Hunde


Rabies in Switzerland: a daily battle. If a case of rabies is suspected, prompt action is vital to protect potentially exposed humans against this deadly zoonosis.

Nathan web 2

Blog - Young researchers from the IVI

Nathan Leborgne : « The targets involved in neutrophil cell survival or inflammation may enable us in the long term to treat diseases such as atherosclerosis or chronic obstructive pulmonary disease ».



Vaccination, Official, Medicines Control Laboratory

Diagnostik Startseite


Animal diseases, reference laboratories

In cooperation with Vetsuisse Faculty